Back to Trades
Sell4
Spyre Therapeutics, Inc.
SYRE
Total Value
$174.1K
Sales
$101.6K
2 transactions
Company Information
- Company Name
- Spyre Therapeutics, Inc.
- Ticker Symbol
- SYRE
- CIK
- 0001636282
Insider Information
- Name
- Burrows Scott L
- Role
- Chief Financial Officer
- Location
- WALTHAM, MA
Filing Details
- Filing Date
- Mar 3, 2026
- Transaction Date
- Mar 3, 2026
- Accession Number
- 0001636282-26-000028
- Form Type
- 4